Parents and school HPV uptake
In BC’s free school HPV program, about 65% of surveyed parents reported first-dose receipt—lower than concurrent hepatitis B and meningitis C consent rates.
Source
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt
What they did
Researchers telephoned a random sample of parents of grade-6 girls eligible for publicly funded school HPV vaccination and analyzed factors associated with vaccine receipt.
What they found
2,025 parents responded (50.2%); 65.1% reported HPV dose 1 vs ~88% hepatitis B and ~86% meningitis C consent in the same program, showing residual hesitancy despite free access.
The limits
What it doesn't show
Self-reported receipt may misclassify doses, and two health areas lacking the registry were excluded.
Key terms
- HPV vaccine
- Vaccine preventing human papillomavirus infection linked to cervical cancer.
- School-based program
- Public health nurses offering vaccines in schools with parental consent.
- Gardasil
- HPV vaccine used in BC’s 2008 grade 6/9 program.
- Vaccine hesitancy
- Delay or refusal despite availability of vaccination services.
- iPHIS
- Provincial immunization registry used for sampling.
- Parental consent
- Parent decision authorizing or declining school vaccination.
Flashcards
Want these cards to stick?
Save the deck to NoteFren and study it with spaced repetition.
Quiz yourself
Design?
Common questions
Who was surveyed?
Parents of grade 6 girls in British Columbia eligible for HPV vaccine.
HPV first-dose report rate?
65.1% (95% CI 63.1–67.1).
How did other school vaccines compare?
Hepatitis B ~88.4% and meningitis C ~86.5% consent.
Was cost a barrier?
Program was publicly funded/free; hesitancy persisted anyway.
More on Vaccination